integrated DNA technologies
ActiveSummary
integrated DNA technologies has been active since 2000 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €15.4m and a net result of €7.7m. Equity remains stable across the filed financial years (±0.8% per year). Its solvency ranks better than 58% of 317 sector peers (NACE 20, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).
Articles of association
- Who signsWho may bind the company towards others, for example by signing a contract.
- “Het mandaat wordt onbezoldigd uitgeoefend. Overeenkomstig artikel 12 van de statuten van de Vennootschap vertegenwoordigt iedere bestuurder…”deed of 27-05-2025
- Director compensationWhether and how directors are paid for their mandate; the general meeting decides.
- “Geen bezoldiging, 0” (deed in Dutch)deed of 01-10-2026
Read from the deeds: 2 provisions, deed of 01-10-2026